Skip to main content
padlock icon - secure page this page is secure

Serotonin 5-HT7 Receptor Antagonists

Buy Article:

$68.00 + tax (Refund Policy)

The 5-HT7R is the most recent addition to the burgeoning family of serotonin receptors. Preliminary evidences suggest that it may be involved in depression, control of circadian rhythms, and relaxation in a variety of vascular smooth muscles, indicating the high potential of 5-HT7R ligands as new therapeutic drugs. During the last four years several selective 5-HT7R antagonists have been discovered, and we have recently contributed to this field with the definition of a pharmacophoric hypothesis for 5-HT7R antagonism and a computational model of ligand-receptor interaction of new naphtholactam and naphthosultam derivatives acting at this receptor. This article will review the development of 5-HT7R antagonists with an emphasis on selective antagonists, their structural requirements and ligand-receptor interactions, as well as the potential therapeutic opportunities surrounding 5-HT7R ligands.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: 5-ht7 receptor antagonists; computational model; ligand-receptor interaction; pharmacophore model; serotonin

Document Type: Review Article

Affiliations: Departamento de Quimica Organica I, Facultad de Ciencias Quimicas, Universidad Complutense, E- 28040 Madrid, Spain

Publication date: September 1, 2004

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more